Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Nephrol Dial Transplant

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    May 2021
  1. AYERDEM G, van Hassel G, Vinke JSJ, Kremer DJ, et al
    Iron deficiency, with and without anemia, across strata of kidney function in kidney transplant recipients.
    Nephrol Dial Transplant. 2021 May 3. pii: 6263840. doi: 10.1093.
    PubMed    


    February 2021
  2. SHUTOV E, Sulowicz W, Esposito C, Tataradze A, et al
    Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, double-blind, placebo-controlled study (ALPS).
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149483. doi: 10.1093.
    PubMed     Abstract available


  3. PROVENZANO R, Shutov E, Eremeeva L, Korneyeva S, et al
    Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149078. doi: 10.1093.
    PubMed     Abstract available


  4. GUEDES M, Muenz D, Zee J, Lopes MB, et al
    Serum biomarkers of iron stores are associated with worse physical health-related quality of life (HRQoL) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with or without anemia.
    Nephrol Dial Transplant. 2021 Feb 24. pii: 6149131. doi: 10.1093.
    PubMed     Abstract available


  5. GOTTA V, Tancev G, Marsenic O, Vogt JE, et al
    Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.
    Nephrol Dial Transplant. 2021;36:519-528.
    PubMed     Abstract available


    January 2021
  6. HODSON EM, Strippoli GFM
    Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation.
    Nephrol Dial Transplant. 2021;36:205-207.
    PubMed    


    December 2020
  7. MONET-DIDAILLER C, Chevallier A, Godron-Dubrasquet A, Allard L, et al
    Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Nephrol Dial Transplant. 2020;35:2147-2153.
    PubMed     Abstract available


    October 2020
  8. ZHENG Q, Yang H, Fu X, Huang Y, et al
    The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2020 Oct 14. pii: 5923003. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  9. MINUTOLO R, Garofalo C, Chiodini P, Aucella F, et al
    Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2020 Aug 23. pii: 5896177. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  10. NANGAKU M, Farag YMK, deGoma E, Luo W, et al
    Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients.
    Nephrol Dial Transplant. 2020 Jul 28. pii: 5877009. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  11. FLOEGE J, Funk F, Ketteler M, Rastogi A, et al
    Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
    Nephrol Dial Transplant. 2020;35:946-954.
    PubMed     Abstract available


    February 2020
  12. BHANDARI S, Kalra PA, Berkowitz M, Belo D, et al
    Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Nephrol Dial Transplant. 2020 Feb 12. pii: 5734687. doi: 10.1093.
    PubMed     Abstract available


  13. GACKLER A, Kaulfuss M, Rohn H, Vogel U, et al
    Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab.
    Nephrol Dial Transplant. 2020;35:298-303.
    PubMed     Abstract available


    October 2019
  14. AWAN AA, Walther CP, Richardson PA, Shah M, et al
    Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
    Nephrol Dial Transplant. 2019 Oct 22. pii: 5602623. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  15. VILLAIN C, Ecochard R, Bouchet JL, Daugas E, et al
    Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients.
    Nephrol Dial Transplant. 2019;34:848-858.
    PubMed     Abstract available


    March 2019
  16. LOCATELLI F, Del Vecchio L
    Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?
    Nephrol Dial Transplant. 2019 Mar 7. pii: 5371147. doi: 10.1093.
    PubMed     Abstract available


  17. SCHAPIRO D, Daga A, Lawson JA, Majmundar AJ, et al
    Panel sequencing distinguishes monogenic forms of nephritis from nephrosis in children.
    Nephrol Dial Transplant. 2019;34:474-485.
    PubMed     Abstract available


    December 2018
  18. TSUJITA M, Kosugi T, Goto N, Futamura K, et al
    The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial.
    Nephrol Dial Transplant. 2018 Dec 17. pii: 5250855. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  19. BLOCK GA, Pergola PE, Fishbane S, Martins JG, et al
    Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
    Nephrol Dial Transplant. 2018 Oct 30. pii: 5149799. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  20. MIN HK, Sung SA, Oh YK, Kim YH, et al
    Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2018 Jul 23. pii: 5057655. doi: 10.1093.
    PubMed     Abstract available


  21. KARABOYAS A, Morgenstern H, Pisoni RL, Zee J, et al
    Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.
    Nephrol Dial Transplant. 2018 Jul 11. pii: 5052242. doi: 10.1093.
    PubMed     Abstract available


  22. HANUDEL MR, Eisenga MF, Rappaport M, Chua K, et al
    Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.
    Nephrol Dial Transplant. 2018 Jul 10. pii: 5051711. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  23. HAASE VH, Chertow GM, Block GA, Pergola PE, et al
    Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.
    Nephrol Dial Transplant. 2018 Apr 16. pii: 4973359. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  24. AGARWAL R
    Mechanisms and mediators of hypertension induced by erythropoietin and related molecules.
    Nephrol Dial Transplant. 2017 Dec 8. pii: 4712017. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  25. BIRNIE K, Caskey F, Ben-Shlomo Y, Sterne JA, et al
    Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.
    Nephrol Dial Transplant. 2017;32:692-698.
    PubMed     Abstract available


    March 2017
  26. CHEN N, Qian J, Chen J, Yu X, et al
    Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
    Nephrol Dial Transplant. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  27. CAVERO T, Rabasco C, Lopez A, Roman E, et al
    Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32:466-474.
    PubMed     Abstract available


    February 2017
  28. FLISER D, Dellanna F, Koch M, Wiggenhauser A, et al
    Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
    Nephrol Dial Transplant. 2017;32:279-287.
    PubMed    


    January 2017
  29. VAN DEN BRAND JA, Verhave JC, Adang EM, Wetzels JF, et al
    Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32.
    PubMed     Abstract available


    September 2016
  30. EVANS M, Carrero JJ, Bellocco R, Barany P, et al
    Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.
    Nephrol Dial Transplant. 2016.
    PubMed     Abstract available


    October 2015
  31. OKPARAVERO A, Foster MC, Tighiouart H, Gudnason V, et al
    Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.
    Nephrol Dial Transplant. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: